- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 8.24M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 8.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 7.83M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $53.33K |
| Capex | Q1 2026 · Mar 31, 2025 | $52.3K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$768.86K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$732.97K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.71M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.03M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $1.71M |
| Cash And Equivalents restated | Q1 2026 · Dec 31, 2024 | $2.49M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.55M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $17.24M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $18.16M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.78M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.44M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.35M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.16M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.47M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.64M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $13.9M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $14.44M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.11 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.13 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $665.38K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $653.42K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.09M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.13M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$899.58K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$994.14K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$759.67K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$893.67K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.9M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $2M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.8M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.97M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.7M |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.97M |